Key Updates in the 2025 Spanish Asthma Guidelines (GEMA 5.5).

作者信息

Almonacid Carlos, Blanco Marina, Ferreira Jorge, García Gabriel, Morete Ana, Quirce Santiago, Soto-Campos Gregorio, Plaza Vicente

机构信息

Hospital Puerta de Hierro Majadahonda, Madrid, Spain.

Complejo Hospitalario Universitario, A Coruña, Spain.

出版信息

Open Respir Arch. 2025 Jun 9;7(3):100453. doi: 10.1016/j.opresp.2025.100453. eCollection 2025 Jul-Sep.

DOI:10.1016/j.opresp.2025.100453

PMID:40677934

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12269484/

Abstract

摘要

相似文献

[1]

Key Updates in the 2025 Spanish Asthma Guidelines (GEMA 5.5).

Open Respir Arch. 2025-6-9

[2]

[Knowledge of and attitudes and adherence to the Spanish Guidelines for Asthma Management (GEMA) among Spanish health care professionals: the GEMA test Project].

Arch Bronconeumol. 2008-5

[3]

Consensus on the Asthma-COPD Overlap Syndrome (ACOS) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA).

Arch Bronconeumol. 2017-5-8

[4]

Factors associated with severe uncontrolled asthma and the perception of control by physicians and patients.

Arch Bronconeumol. 2014-9

[5]

The integration of geographic methods and ecological momentary assessment in public health research: A systematic review of methods and applications.

Soc Sci Med. 2024-8

[6]

GEMA 5.3. Spanish Guideline on the Management of Asthma.

Open Respir Arch. 2023-9-19

[7]

Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies.

Arch Bronconeumol. 2022-2

[8]

Highlights of the Spanish Asthma Guidelines (GEMA), version 5.0.

Arch Bronconeumol (Engl Ed). 2021-1

[9]

Obsolete anti-pneumococcal vaccination recommendations in the spanish guidelines for the management of asthma (GEMA 4.0): The authors reply.

Arch Bronconeumol. 2016-8

[10]

[Translated article] Spanish Asthma Management Guidelines (GEMA) v.5.1. Highlights and Controversies.

Arch Bronconeumol. 2022-2

本文引用的文献

[1]

Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps.

N Engl J Med. 2025-3-27

[2]

Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials.

Lancet. 2025-3-15

[3]

Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial.

Lancet Respir Med. 2025-1

[4]

Efficacy and safety of benralizumab in eosinophilic granulomatosis with polyangiitis: A meta-analysis of eight studies.

Eur J Clin Invest. 2025-2

[5]

Once or consecutive administration of inhaled salbutamol in children with acute asthma exacerbation: Is an additional dose beneficial?

Pediatr Pulmonol. 2024-12

[6]

Spanish Consensus on Remission in Asthma (REMAS).

Arch Bronconeumol. 2024-8

[7]

Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses.

Eur Respir J. 2024-4

[8]

Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis.

J Allergy Clin Immunol Pract. 2024-3

[9]

Relationship Between Birth Weight and Asthma Diagnosis: A Cross-Sectional Survey Study Based on the National Survey of Children's Health in the U.S.

BMJ Open. 2023-12-1

[10]

Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma.

Am J Respir Crit Care Med. 2024-2-1

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Key Updates in the 2025 Spanish Asthma Guidelines (GEMA 5.5).

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

本文引用的文献